BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMKR
4076
DELISTED
Emcore Corp
EMKR
| $1.71M | ﹤0.01% |
55,806
-174,349
| -76% | -$5.87M |
|
|
ETNB
4077
DELISTED
89bio
ETNB
| $1.7M | ﹤0.01% |
527,365
-394,865
| -43% | -$1.19M |
|
4078
OP Bancorp
OPBK
$237M
| $1.7M | ﹤0.01% |
161,772
+869
| +0.5% | +$10.6K |
|
4079
Bioceres Crop Solutions
BIOX
$23.6M
| $1.69M | ﹤0.01% |
123,562
+4,078
| +3% | +$54.1K |
|
4080
Great Elm Group
GEG
$74M
| $1.69M | ﹤0.01% |
787,954
+440,459
| +127% | +$882K |
|
|
SURF
4081
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $1.69M | ﹤0.01% |
1,033,030
-1,515,075
| -59% | -$3.15M |
|
|
EARN
4082
Ellington Residential Mortgage REIT
EARN
$164M
| $1.69M | ﹤0.01% |
226,430
+2,150
| +1% | +$17.8K |
|
|
HGEN
4083
DELISTED
HUMANIGEN, INC.
HGEN
| $1.68M | ﹤0.01% |
949,594
-2,417,421
| -72% | -$5.43M |
|
|
PRTK
4084
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.68M | ﹤0.01% |
869,224
-2,071,289
| -70% | -$4.52M |
|
4085
Culp Inc
CULP
$44.2M
| $1.68M | ﹤0.01% |
389,344
-12,482
| -3% | -$76.6K |
|
4086
Annovis Bio
ANVS
$73.2M
| $1.66M | ﹤0.01% |
146,812
-881
| -0.6% | -$9.63K |
|
4087
InfuSystem Holdings
INFU
$186M
| $1.66M | ﹤0.01% |
172,048
-809,792
| -82% | -$7.09M |
|
4088
VanEck Intermediate Muni ETF
ITM
$2.14B
| $1.65M | ﹤0.01% |
36,164
+18,566
| +106% | +$848K |
|
|
NAGE
4089
Niagen Bioscience
NAGE
$281M
| $1.65M | ﹤0.01% |
988,889
-2,164,820
| -69% | -$4.23M |
|
|
RJET
4090
Republic Airways Holdings
RJET
$990M
| $1.65M | ﹤0.01% |
50,285
-115,052
| -70% | -$5.41M |
|
|
GOL
4091
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $1.65M | ﹤0.01% |
484,081
-23,213
| -5% | -$131K |
|
4092
Forum Energy Technologies
FET
$795M
| $1.65M | ﹤0.01% |
83,934
-3,734
| -4% | -$83K |
|
|
OTIC
4093
DELISTED
Otonomy, Inc.
OTIC
| $1.65M | ﹤0.01% |
790,821
-9,984
| -1% | -$20.8K |
|
4094
Horizon Technology Finance
HRZN
$308M
| $1.64M | ﹤0.01% |
141,951
+19,817
| +16% | +$248K |
|
4095
Immunic
IMUX
$192M
| $1.64M | ﹤0.01% |
47,165
-84,283
| -64% | -$5.4M |
|
4096
inTEST
INTT
$167M
| $1.64M | ﹤0.01% |
239,744
+359
| +0.1% | +$2.83K |
|
4097
Schwab US Large- Cap ETF
SCHX
$72.9B
| $1.63M | ﹤0.01% |
109,671
+13,338
| +14% | +$216K |
|
4098
Cytosorbents Corp
CTSO
$23.1M
| $1.63M | ﹤0.01% |
744,958
-1,855,479
| -71% | -$4.26M |
|
4099
Quantum Corp
QMCO
$416M
| $1.63M | ﹤0.01% |
57,365
-139,661
| -71% | -$5.29M |
|
4100
Twin Disc
TWIN
$334M
| $1.63M | ﹤0.01% |
179,563
-1,023
| -0.6% | -$12.5K |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,355 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.